Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBI-4000 in axillary hyperhidrosis
NCT02058264Phase 1Completed
- Sponsor
- Botanix Pharmaceuticals
- Start
- Feb 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of sofpironium in axillary hyperhidrosis (2 arms), sponsored by Botanix Pharmaceuticals. Primary endpoint: Percent change in the gravimetrically measured sweat production from baseline at Week 2. Started Feb 2014; status: completed.
02
Drugs
sofpironium
03
Conditions
axillary hyperhidrosis
Beyond the preview
Go deeper on NCT02058264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058264.